Tirzepatide vs Semaglutide — Which GLP-1 Is Right for You?
Tirzepatide vs Semaglutide — What's the Difference?
Two of the most effective medications available for medically supervised weight loss are Semaglutide and Tirzepatide. Both belong to the GLP-1 class of medications, but they work in slightly different ways — and understanding the difference can help you and your provider make the best decision for your health goals.
At Slender Me Medical, we offer both compounded Semaglutide and Tirzepatide programs through our in-office and telehealth services. Here's a breakdown of how they compare.
What is Semaglutide?
Semaglutide is a GLP-1 receptor agonist — meaning it mimics the GLP-1 hormone your body naturally produces after eating. GLP-1 helps regulate blood sugar, slows digestion, and signals your brain that you're full. By activating these receptors, Semaglutide helps reduce appetite, decrease food cravings, and support weight loss over time.
Semaglutide is the active ingredient in the brand-name medications Ozempic® (approved for diabetes) and Wegovy® (approved for weight loss). At Slender Me Medical, we offer compounded Semaglutide, which is not the same as these brand-name products.
What is Tirzepatide?
Tirzepatide is a newer medication that works on two receptors — GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). This dual-action approach is one reason Tirzepatide has shown impressive results in clinical studies, with some patients achieving greater weight loss compared to GLP-1-only medications.
Tirzepatide is the active ingredient in brand-name Mounjaro® (approved for diabetes) and Zepbound® (approved for weight loss). At Slender Me Medical, we offer compounded Tirzepatide, which is not the same as these brand-name products.
How Do They Compare?
Mechanism: Semaglutide activates GLP-1 receptors only. Tirzepatide activates both GLP-1 and GIP receptors, which may enhance its effectiveness for weight loss in some patients.
Weight Loss Potential: Both medications have demonstrated meaningful weight loss in clinical studies. Tirzepatide's dual-action mechanism has shown strong results, though individual responses vary significantly.
Side Effects: Both medications share similar side effect profiles — nausea, vomiting, diarrhea, constipation, and decreased appetite are the most common. These tend to be more pronounced in the early weeks and improve over time with proper dose titration.
Dosing: Both are weekly injections that follow a step-up dosing protocol, starting at a low dose and gradually increasing over several months.
Cost: At Slender Me Medical, Semaglutide starts at $297/month and Tirzepatide starts at $368/month for your first month supply.
Which One Is Right for Me?
The best medication for you depends on your individual health history, goals, and how your body responds to treatment. Our licensed nurse practitioner will review your health history, discuss your goals, and help determine which program is the best fit for you during your consultation.
Some patients do better with Semaglutide. Others see better results with Tirzepatide. There's no one-size-fits-all answer — which is exactly why personalized medical supervision matters.
Get Started at Slender Me Medical
Whether you're interested in Semaglutide or Tirzepatide, Slender Me Medical's medically supervised weight loss program is designed to help you achieve real, lasting results. Our programs are available via telehealth for patients in California and Arizona, and in-office at our Corona, CA location.
Call us at (951) 898-8515 or shop our weight loss programs online to get started today.
Disclaimer: Both Semaglutide and Tirzepatide offered through Slender Me Medical are compounded prescription medications and have not been approved by the FDA. A clinical consultation and provider approval are required. Individual results may vary. This article is for informational purposes only and does not constitute medical advice.